<DOC>
	<DOCNO>NCT01359345</DOCNO>
	<brief_summary>Recently increase report NEPHROGENIIC SYSTEMIC FIBROSIS ( NSF ) patient severe renal failure mainly patient dialysis gadollinum use . The investigator evaluate prevalence severity NSF patient different degree renal failure underwent imaging Gadolinum .</brief_summary>
	<brief_title>Nephrogenic Systemic Fibrosis With Gadollinum</brief_title>
	<detailed_description>NSF progressive potentially fatal disease report mainly End Stage Renal Disease ( ESRD ) patient Gadolinume use contrast agent . Skin main organ involvement vital organ like myocard , lung , liver may also involved.Gadollinum know safe contrast renal disease patient comparison conventional nephrotoxic radiocontrast agent , increase report NSF Gadollinum use agent renal failure patient question . We retrospectively evaluate occurrence complication patient different degree renal failure underwent MRA MRI Gadollinum Tehran Heart Center since 2003 till describe severity distribution pattern lesion relation complication severity renal failure .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Nephrogenic Fibrosing Dermopathy</mesh_term>
	<criteria>Renal Failure Use Gadollinum No consent Age 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>NSF</keyword>
	<keyword>ESRD</keyword>
	<keyword>MRA</keyword>
	<keyword>MRI</keyword>
	<keyword>occurrence NSF</keyword>
	<keyword>Use Gadollinum</keyword>
</DOC>